In this video, we share the courageous journey of a patient diagnosed with mantle cell lymphoma (MCL), a rare and aggressive type of non-Hodgkin lymphoma. After undergoing multiple rounds of chemotherapy and trying targeted therapies — all without success — hope seemed to be slipping away.
That hope was reignited with CARTEYVA, a CAR-T cell therapy developed in China. This groundbreaking immunotherapy offered a new path forward when all other options had failed.
Join us as the patient opens up about his diagnosis, the emotional and physical toll of failed treatments, and how CARTEYVA became the turning point in his fight against MCL. Whether you’re a patient, caregiver, or someone interested in the latest cancer treatments, this story sheds light on the real impact of CAR-T therapy and the resilience of the human spirit.
